Semler Scientific, Inc. (SMLR)
USD 33.51
(-1.63%)
USD 33.51
(-1.63%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 78.06 Million USD | 24.52% |
| 2022 | 62.69 Million USD | 23.72% |
| 2021 | 50.67 Million USD | 46.29% |
| 2020 | 34.63 Million USD | 89.42% |
| 2019 | 18.28 Million USD | 136.91% |
| 2018 | 7.71 Million USD | 82.14% |
| 2017 | 4.23 Million USD | 37.96% |
| 2016 | 3.07 Million USD | -0.23% |
| 2015 | 3.07 Million USD | -58.95% |
| 2014 | 7.5 Million USD | 335.03% |
| 2013 | 1.72 Million USD | 16.8% |
| 2012 | 1.47 Million USD | 118.99% |
| 2011 | 674 Thousand USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q2 | 84.78 Million USD | 1.11% |
| 2024 Q1 | 83.85 Million USD | 7.42% |
| 2024 Q3 | 92.19 Million USD | 8.74% |
| 2023 FY | 78.06 Million USD | 24.52% |
| 2023 Q2 | 75.46 Million USD | 7.41% |
| 2023 Q3 | 79.44 Million USD | 5.28% |
| 2023 Q4 | 78.06 Million USD | -1.73% |
| 2023 Q1 | 70.25 Million USD | 12.07% |
| 2022 Q2 | 57.63 Million USD | 3.97% |
| 2022 Q1 | 55.43 Million USD | 9.4% |
| 2022 Q4 | 62.69 Million USD | 2.91% |
| 2022 FY | 62.69 Million USD | 23.72% |
| 2022 Q3 | 60.91 Million USD | 5.7% |
| 2021 Q3 | 50.97 Million USD | 10.84% |
| 2021 Q1 | 40.64 Million USD | 17.34% |
| 2021 FY | 50.67 Million USD | 46.29% |
| 2021 Q2 | 45.98 Million USD | 13.15% |
| 2021 Q4 | 50.67 Million USD | -0.59% |
| 2020 Q4 | 34.63 Million USD | 23.5% |
| 2020 FY | 34.63 Million USD | 89.42% |
| 2020 Q1 | 19.63 Million USD | 7.38% |
| 2020 Q2 | 21.38 Million USD | 8.92% |
| 2020 Q3 | 28.04 Million USD | 31.14% |
| 2019 FY | 18.28 Million USD | 136.91% |
| 2019 Q1 | 9.05 Million USD | 17.31% |
| 2019 Q2 | 9.82 Million USD | 8.49% |
| 2019 Q3 | 18.85 Million USD | 91.95% |
| 2019 Q4 | 18.28 Million USD | -3.02% |
| 2018 Q4 | 7.71 Million USD | 9.6% |
| 2018 Q1 | 4.25 Million USD | 0.45% |
| 2018 Q2 | 5.31 Million USD | 24.78% |
| 2018 Q3 | 7.04 Million USD | 32.59% |
| 2018 FY | 7.71 Million USD | 82.14% |
| 2017 Q3 | 3.87 Million USD | 22.69% |
| 2017 Q1 | 3.11 Million USD | 1.43% |
| 2017 FY | 4.23 Million USD | 37.96% |
| 2017 Q4 | 4.23 Million USD | 9.48% |
| 2017 Q2 | 3.15 Million USD | 1.25% |
| 2016 Q2 | 3.06 Million USD | -10.63% |
| 2016 FY | 3.07 Million USD | -0.23% |
| 2016 Q4 | 3.07 Million USD | 3.78% |
| 2016 Q1 | 3.42 Million USD | 11.24% |
| 2016 Q3 | 2.96 Million USD | -3.3% |
| 2015 FY | 3.07 Million USD | -58.95% |
| 2015 Q4 | 3.07 Million USD | -12.53% |
| 2015 Q3 | 3.52 Million USD | -38.01% |
| 2015 Q2 | 5.67 Million USD | -11.32% |
| 2015 Q1 | 6.4 Million USD | -14.63% |
| 2014 Q4 | 7.5 Million USD | 3.78% |
| 2014 Q2 | 7.65 Million USD | -12.4% |
| 2014 Q3 | 7.22 Million USD | -5.62% |
| 2014 FY | 7.5 Million USD | 335.03% |
| 2014 Q1 | 8.74 Million USD | 407.02% |
| 2013 FY | 1.72 Million USD | 16.8% |
| 2013 Q2 | 864 Thousand USD | -84.81% |
| 2013 Q3 | 2.38 Million USD | 175.69% |
| 2013 Q4 | 1.72 Million USD | -27.62% |
| 2013 Q1 | 5.68 Million USD | 285.3% |
| 2012 Q4 | 1.47 Million USD | 0.0% |
| 2012 FY | 1.47 Million USD | 118.99% |
| 2011 FY | 674 Thousand USD | 0.0% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -148.884% |
| BrainsWay Ltd. | 62.97 Million USD | -23.968% |
| Cerus Corporation | 197.74 Million USD | 60.523% |
| Envoy Medical, Inc. | 7.64 Million USD | -921.793% |
| electroCore, Inc. | 16.38 Million USD | -376.384% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -914.886% |
| IceCure Medical Ltd | 16.41 Million USD | -375.716% |
| Inogen, Inc. | 326.19 Million USD | 76.068% |
| OrthoPediatrics Corp. | 449.58 Million USD | 82.636% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -186.267% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -370.867% |
| MaxCyte, Inc. | 268.27 Million USD | 70.901% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -864.085% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2049.416% |
| Orthofix Medical Inc. | 925.31 Million USD | 91.563% |
| PAVmed Inc | 33.11 Million USD | -135.711% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 45.581% |
| RxSight, Inc. | 182.55 Million USD | 57.236% |
| Sight Sciences, Inc. | 166.65 Million USD | 53.157% |
| SI-BONE, Inc. | 230.42 Million USD | 66.121% |
| TELA Bio, Inc. | 78.04 Million USD | -0.022% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 69.01% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -627.54% |
| Acutus Medical, Inc. | 53.96 Million USD | -44.672% |
| Talis Biomedical Corporation | 98.34 Million USD | 20.617% |
| Spectral AI, Inc. | 10.69 Million USD | -630.125% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 64.296% |
| CVRx, Inc. | 115.22 Million USD | 32.252% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | -33.078% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -2405.896% |
| Bioventus Inc. | 810.91 Million USD | 90.373% |
| Venus Concept Inc. | 93.65 Million USD | 16.645% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -203.46% |
| LivaNova PLC | 2.42 Billion USD | 96.787% |
| 908 Devices Inc. | 202.98 Million USD | 61.541% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 90.305% |
| Nemaura Medical Inc. | 14.56 Million USD | -436.042% |
| NeuroPace, Inc. | 107.65 Million USD | 27.483% |
| LENSAR, Inc. | 69.58 Million USD | -12.187% |
| Apyx Medical Corporation | 79.24 Million USD | 1.483% |
| Cutera, Inc. | 346.29 Million USD | 77.457% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | -85.798% |
| BioSig Technologies, Inc. | 1.79 Million USD | -4241.769% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 71.155% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | -82.989% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 97.936% |
| Axonics, Inc. | 719.92 Million USD | 89.156% |
| Outset Medical, Inc. | 313.8 Million USD | 75.123% |
| IRIDEX Corporation | 34.43 Million USD | -126.696% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 80.711% |
| IRadimed Corporation | 92.15 Million USD | 15.29% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -1385.82% |
| INVO Bioscience, Inc. | 20.88 Million USD | -273.735% |
| Telesis Bio, Inc. | 70.41 Million USD | -10.87% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 49.342% |
| Varex Imaging Corporation | 1.24 Billion USD | 93.753% |
| Quipt Home Medical Corp. | 247.4 Million USD | 68.447% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -738.507% |
| Pulmonx Corporation | 178.95 Million USD | 56.376% |
| Dynatronics Corporation | 25.94 Million USD | -200.938% |
| Modular Medical, Inc. | 13.8 Million USD | -465.402% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -627.743% |
| InMode Ltd. | 863.28 Million USD | 90.957% |
| Bruker Corporation | 4.24 Billion USD | 98.163% |
| Cytosorbents Corporation | 53.26 Million USD | -46.572% |
| DexCom, Inc. | 6.26 Billion USD | 98.754% |
| Align Technology, Inc. | 6.08 Billion USD | 98.717% |
| Viveve Medical, Inc. | 25.91 Million USD | -201.258% |
| ZimVie Inc. | 1.2 Billion USD | 93.523% |
| Movano Inc. | 9.42 Million USD | -728.628% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 84.314% |
| Nexalin Technology, Inc. | 3.63 Million USD | -2049.416% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | -33.078% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 91.806% |
| Profound Medical Corp. | 43.68 Million USD | -78.694% |
| Insulet Corporation | 2.58 Billion USD | 96.984% |
| enVVeno Medical Corporation | 48.63 Million USD | -60.512% |
| Surmodics, Inc. | 185.73 Million USD | 57.969% |
| iCAD, Inc. | 41.41 Million USD | -88.481% |
| Nuwellis, Inc. | 9.77 Million USD | -699.028% |
| Biotricity, Inc. | 5.94 Million USD | -1213.645% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 81.977% |
| Aethlon Medical, Inc. | 8.24 Million USD | -846.703% |
| InspireMD, Inc. | 47.64 Million USD | -63.854% |
| PAVmed Inc. | 33.11 Million USD | -135.711% |
| BIOLASE, Inc. | 35.1 Million USD | -122.401% |
| Beyond Air, Inc. | 56.96 Million USD | -37.05% |
| FONAR Corporation | 214.24 Million USD | 63.563% |
| AxoGen, Inc. | 196.82 Million USD | 60.338% |
| Vivani Medical, Inc. | 45.79 Million USD | -70.459% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 72.262% |
| Inari Medical, Inc. | 674.23 Million USD | 88.422% |
| UFP Technologies, Inc. | 404.13 Million USD | 80.683% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -233.632% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -721.468% |
| Tenon Medical, Inc. | 6.34 Million USD | -1130.339% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -729.861% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 24.682% |
| AdaptHealth Corp. | 4.61 Billion USD | 98.31% |
| Sintx Technologies, Inc. | 15.36 Million USD | -408.07% |
| NanoVibronix, Inc. | 6.67 Million USD | -1069.688% |
| Quanterix Corporation | 425.01 Million USD | 81.632% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -738.507% |
| Sensus Healthcare, Inc. | 53.72 Million USD | -45.299% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 95.529% |
| TransMedics Group, Inc. | 706.04 Million USD | 88.943% |
| ReWalk Robotics Ltd. | 63.19 Million USD | -23.536% |
| NeuroMetrix, Inc. | 21.42 Million USD | -264.374% |
| Hyperfine, Inc. | 94.19 Million USD | 17.128% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 70.941% |
| Biomerica, Inc. | 9.25 Million USD | -743.581% |
| Bone Biologics Corporation | 3.73 Million USD | -1988.549% |
| AVITA Medical, Inc. | 144.33 Million USD | 45.916% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -1503.461% |
| Silk Road Medical, Inc | 265.3 Million USD | 70.576% |